Trial Profile
A study of HSRx 351 in combination with oseltamivir for the prevention and treatment of influenza.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2016
Price :
$35
*
At a glance
- Drugs HSRx 351 (Primary) ; Oseltamivir
- Indications Influenza virus infections
- Focus Adverse reactions; Therapeutic Use
- 07 Dec 2016 New trial record